Tumour necrosis factor and Crohn's disease.

SJ Van Deventer - Gut, 1997 - ncbi.nlm.nih.gov
The production of several pro-inflammatory cytokines is increased in inflammatory bowel
diseases (IBD). Experimental models of IBD have further defined the importance of specific …

Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.

SH Murch, CP Braegger, JA Walker-Smith… - Gut, 1993 - gut.bmj.com
This study determined the location and tissue density of cells immunoreactive for tumour
necrosis factor alpha (TNF alpha) in intestinal specimens from 24 patients with chronic …

[HTML][HTML] Study of tumor necrosis factor receptor in the inflammatory bowel disease

RF Souza, MAF Caetano, HIR Magalhães… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Ulcerative colitis (UC) and Crohn's disease (CD) are part of Inflammatory Bowel Diseases
(IBD) and have pathophysiological processes such as bowel necrosis and enteric neurons …

Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice

MF Neurath, I Fuss, M Pasparakis… - European journal of …, 1997 - Wiley Online Library
Antibodies to tumor necrosis factor (TNF)‐α have been recently proposed as effective
treatment for patients with Crohn's disease. Here, we analyze the functional role of TNF‐α in …

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)

HM Van Dullemen, SJH van Deventer, DW Hommes… - Gastroenterology, 1995 - Elsevier
Background & Aims: Increased concentrations of tumor necrosis factor (TNF), a potent
proinflammatory cytokine, can be shown in the mucosa of patients with active Crohn's …

Tumor necrosis factor: biology and therapeutic inhibitors

KA Papadakis, SR Targan - Gastroenterology, 2000 - Elsevier
Tumor necrosis factor (TNF) was originally described as a protein factor capable of killing
tumor cells in vitro and causing hemorrhagic necrosis of transplantable tumors in mice. 1, 2 …

targeting TNFα as a key cytokine in the inflammatory processes of Crohn's disease—the mechanisms of action of infliximab

SJH Van Deventer - Alimentary pharmacology & therapeutics, 1999 - Wiley Online Library
Crohn's disease is a chronic, debilitating gastrointestinal disorder in which a variety of
cellular processes and pro‐inflammatory mediators influence the pathogenesis of the …

Serum tumor necrosis factor activity in inflammatory bowel disease

M Maeda, N Watanabe, H Neda… - …, 1992 - Taylor & Francis
Serum tumor necrosis factor (TNF) levels in 33 patients with inflammatory bowel disease
(IBD) were measured by using a sensitive enzyme immunoassay. Four of five Crohn's …

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety

WJ Sandborn, SB Hanauer - Inflammatory bowel diseases, 1999 - Wiley Online Library
Tumor necrosis factor‐α (TNFα), a proinflammatory cytokine, plays an important role in the
pathogenesis of inflammatory bowel disease (IBD). Biotechnology agents including a …

Transmembrane TNF-α, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn's disease

SJH Van Deventer - Gastroenterology, 2001 - Elsevier
Tumor necrosis factor (TNF)-α is a potent proinflam-matory cytokine that orchestrates
inflammatory responses by activating a wide range of cells. These effects are mediated by …